Friday, October 5, 2012
(Opinion) Afghanistan: despair would be a good thing
There is much to be said about Afghanistan, from its culture to its recent history of turmoil, grief, and political-economic dysfunction but what can't be said is that Afghanistan, for all the efforts of NATO and the UN, will come out from the other side, if such a side exists. What it would take to get Afghanistan on its feet would mean more blood and treasure for the occupying forces as Afghanistan has been on its knees for a long time.
From the British Empire, to the Soviets, and now the United States, Afghanistan has been in a state of constant conflict with foreign powers and local warlords all scrambling for their share of Afghanistan future with normal Afghans trying to survive the carnage in the middle. The violence in Afghanistan is still rampant, death prevalent, hope dimming and reality damning.
To see the full article, follow this link to filmannex.com
Labels:
Afghanistan,
Barack Obama,
filmannex,
NATO,
opinion,
politics,
U.S.,
UK
Wednesday, October 3, 2012
(sports) Cricket:Twenty20 World Cup Pay Difference Highlights Gender Inequality
It only received very brief headlines, but the recent controversy over the living allowance disparity between male and female cricketers at the twenty20 world cup highlights some continuing worrying trends in the world of sport as a whole.
England
captain Charlotte Edwards started the ‘controversy’ when she suggested that
World Twenty20 chiefs would need to review the pay divide in the daily living
allowance offered to women and men. Female cricketers at the 2012 Twenty20
world cup in Sri Lanka receive a daily allowance of £37 per day. Male
cricketers at the 2012 Twenty20 world cup in the same country playing in an
event organised by the same governing body have been receiving a daily living
allowance of £61 per day. It was also noted that female cricketers were flown
out to the subcontinent in economy class, while male cricketers travelled
business class.
The
first striking thing about these numbers might actually be the sheer quantity
of money that cricketers receive for a living allowance. £259 per week isn’t a
small amount when all of your basic expenses are handled for you. Male
cricketers at the Twenty20 world cup have over £400 per week to spend on food
and for entertainment purposes. That isn’t a bad perk for an already very good
job.
It
should also be mentioned that female cricketers are probably not overly
concerned about having to survive off of ‘only’ £37 per day. Edwards was quick
to state that ‘Our focus is on the cricket at the moment and not on how much
money we get’. Of course there is more to playing cricket for your country then
how much money you make.
However, there are also some pretty clear principles
that it would be pretty sensible to follow. There is absolutely no reason that
men would need a living allowance worth £24 more per day than women. It can be
argued that the discrepancy in the prize money is a result of their simply
being a lot more money in the men’s game in general (the winning men’s team
takes home £616,000, while the women’s winner collect £40,000). That is still a
questionable issue, but a more complex one at least. The difference in daily
living allowances at the Twenty20 world cup can only be put down to sexual
discrimination. Logistically speaking it might actually have been a lot easier
to split the money up more evenly.
So,
what’s the point? A difference in living allowances doesn’t seem to be a major
issue compared to some of the other problems of sexism in sport, which are
present at both a professional and recreational level, and start at a very
young age.
Neither will simply evening up the living allowances fix these
bigger problems. The point is rather that this difference is symptomatic and
representative of the wider problems. It really shows a complete disregard for
the equality that the sport should be striving for. If the game’s own governing
bodies have sat down and produced a difference in budgeting that is a complete
insult to the idea of equality, then what hope is there for improved gender
equality in cricket in general?
Cricket
isn’t the only sport that has this problem. Women’s football is the third
largest team sport in the UK, but this is not at all represented in terms of
sponsorship deals or in terms of television rights. Surveys including both
genders suggest that the publicising of women’s sport via television is
something that the majority of people would welcome.
The
evidence from the few sports that have offered stronger support to the women’s
game is that this is correct. At Wimbledon, the prize money for women and men
is the same. Women’s tennis draws in comparable sized audiences both in the
stands and on television to the men’s game. Does this mean that sexism is
absent from tennis? Of course not, there are still problems with the perception
of female tennis stars and with the general culture surrounding the sport. But
the sport’s governing bodies do at least seem to be taking the issue of
improving gender equality seriously.
Another
example is women’s basketball in the United States. The Women’s National
Basketball Association (WNBA) runs its league throughout the summer and
receives prime television time on ESPN. While there are still some serious
issues with the size of contracts, especially compared with the staggering figures
made by NBA players, the WNBA has forged itself as an independent and effective
sports league. It is widely recognised as such and generally popular. This is
mirrored in college basketball, where the women’s tournament takes place
alongside the men’s tournament and is a key component in helping the period
maintain its name ‘March Madness’.
The
daily living allowance handed out at the Twenty20 world cup may seem like a
minor micro issue that just needs to be fixed behind closed doors, but the
reality is that it is a part of some far larger institutional problems. The
claim here is not that the problems with gender equality in sports can be
magically fixed, or that there are models of gender equality that need to be
followed.
There
is a huge amount of work that needs to be done to improve this situation, and a
lot of it will need to be ‘bottom up’. However, it is also incredibly important
that the top governing bodies take the issue of gender equality seriously, and
engage with it. It’s very hard to find the evidence to suggest that they have
done that so far and the difference in the daily living allowance at the
Twenty20 world cup, and in fact the complete lack of real scandal surrounding
it, are just further proof that serious engagement is just not happening at
this time.
Labels:
2012,
Cricket,
cricket world cup,
england,
inequality,
sports,
Twenty20
(Opinion) Pharmaceutical Industry Controversy: You Can’t Trust Your Medicine
The truth is out about medically
prescribed drugs. If you were hoping that the drugs prescribed to help cure
your illnesses by your doctors were thoroughly and transparently tested by responsible
and unbiased professionals, then I am afraid you will be disappointed. The good
news is that you can still trust your local doctor as much as you did before.
Your physicians are not acting maliciously towards you at all. The bad news is
that the legal framework of the pharmaceutical industry appears to be
specifically constructed to allow the pharmaceutical industry to put drugs into
the marketplace regardless of their effectiveness and regardless of their potential
negative side effects.
Okay,
so let’s talk this through. Medical professionals will tell you that very few
if any medical drugs are perfect and that drugs have varying degrees of success
with different people and even drugs that are extremely helpful can have
negative side effects. However, there is a very basic expectation that when you
are prescribed medicine, it will be have been proven that that medicine can
have some sort of positive effect on your health, and that the doctor
prescribing you that medicine will have enough information to decide whether
the benefits outweigh the side effects of the drug they are prescribing.
This
article will contest that the recent controversies surrounding the
pharmaceutical industry show that not only is this basic expectation not being
met, but that legal and systematic processes are insuring that it isn’t. Recent
findings paint a picture of an industry that prioritises its own financial gain
over any concern for health or even a basic sense of morality.
Ben
Goldacre recently published some absolutely incredible data in his recent book
that demonstrates the pharmaceutical industry actively deceiving physicians and
the general population. Reboxetine is marketed as an antidepressant used to
treat clinical depression, panic disorder and ADHD. If you read up on the drug
it will show you a convincing list of seemingly well-designed tests with
positive results. The drug is reported as performing better in trials both
against a placebo and other antidepressants.
However,
in October 2010 the full picture of Reboxetine was finally revealed by a group
of researchers. Seven trials had been conducted with only one showing positive
results, but the company elected to publish the only positive results. It
should be made clear at this point that there is no legal requirement for all
trial results to be revealed. However, once the other six trials were brought
to light, they showed a shocking tale of deceit. In all six trials it was shown
that Reboxetine was no better than a dummy sugar pill.
The trials showed 507
patients benefitted more from Reboxetine over other drugs with all of those
results being published. A further 1,657 patients worth of data clearly
demonstrated without question that Reboxetine was no better than other drugs.
It seems that the current structures allow the pharmaceutical industry to
actively discount three quarters of the data from their trials.Even
more worrying is that Reboxetine actually displayed several negative side
effects on certain trial subjects. This was not reported because the trials
were simply discounted. Officially, they were never conducted.
An even
more horrific example is the case of paroxetine in children. Paroxetine is
another anti-depressant drug. GlaxoSmithKline conducted trials of the drug on
children with no benefits shown. The company decided not to reveal this
information and internal documents actually revealed a deliberate cover up of
the trial results to protect the company’s interests. During that time 32,000
prescriptions were given to children by doctors believing the pharmaceutical
industry’s claim that the drug worked.
Not only did GSK withhold the fact that
the drugs were ineffective, but they also withheld much more serious
information about its side effects. A legal loophole meant that GSK did not have
to inform the regulator of the side effects on children from Parexotine.
Parexotine’s safety data was not revealed to the regulator because the drug
doesn’t have specific market authorisation for use on children. The side effect
that wasn’t reported was that Parexotine increased the risk of suicide in
children.
GSK
were not legally obligated to report the findings of their safety tests. The
pharmaceutical industry, an industry responsible for producing medicine,
prioritised their reputation and financial gain over the health and safety of
children; children whose doctors had judged needed to be treated with
anti-depressants. It might be worth dwelling on that point. Children who needed
treatment for issues like depression and panic disorder were prescribed a drug
that not only wouldn’t help them, but could increase the risk of their
committing suicide, and there were people who knew this, people who could have
prevented it.
There
are no mysteries surrounding the people who are perpetrating these travesties.
In 2010, academics in Toronto and Harvard researched a huge range of drug
trials and found that 85% of industry funded drug trials turned up positive
results, while government funded trials produced a success rate of just 50%.
This is far too large of a gulf to be anything besides manipulation. Besides
the fact that researchers are free to bury any negative results and at times
academics and researchers are even contractually obliged to maintain secrecy,
there are also other ways in which these trials can be manipulated. Researchers
can watch results as they come in, intervene at any point and even test their
drug against other drugs that they know do not work. This isn’t the way in which
science or medicine production is supposed to work.
The
pharmaceutical industry can only be trusted to act in its own financial
interest. This is a fact about businesses that is generally accepted in
society, but there has always been an implicit assumption that the production
of medical drugs was regulated and designed to ensure the health and safety of
the patients that will eventually be prescribed them. Private industry cannot
even be trusted to inform doctors of an extremely harmful side effect for a
drug being prescribed to children. The case of the pharmaceutical industry
would seem to be yet another argument against the privatisation of NHS
services. The consequences for allowing market and capital to take priority
over social responsibility can be truly catastrophic.
Labels:
2012,
Ben Goldacre,
corporations,
GSK,
Pharma,
politics,
science,
UK,
US embassy
Subscribe to:
Posts (Atom)

